Horizon (HZNP) Submits sBLA for Krystexxa Label Expansion

Published on January 11, 2022

Horizon (HZNP) files a supplemental biologics license application to the FDA for Krystexxa plus methotrexate to treat people living with uncontrolled gout.

Continue reading on website
Other news

The Zacks Analyst Blog Highlights: Nikon, Computer Task Group, Toyota Motor, Mitsui & Co. and Dillard's Inc

January 11, 2022
Nikon, Computer Task Group, Toyota Motor, Mitsui & Co. and Dillard's Inc are included in this analyst blog.

Making Data Security Compliance a Revenue Driver

January 11, 2022
The SolarWinds cybersecurity attack and CNA breach have made corporate data security certification a higher priority than ever - not least in the customer acquisition process - and there are ways of making this significant investment pay additional dividends.